Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “chronic myeloid leukemia”
A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
ClinicalTrials.gov study NCT01342679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00732186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to
ClinicalTrials.gov study NCT02197676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107
ClinicalTrials.gov study NCT01368523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT00324077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03348033. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00053144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02602314. IPD Sharing: NO. Countries: 2. Publications: 0.
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05130138. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy
ClinicalTrials.gov study NCT06692803. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01490983. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02034227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT06629584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03625388. IPD Sharing: NO. Countries: 4. Publications: 0.
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00464113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)
ClinicalTrials.gov study NCT01221376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
ClinicalTrials.gov study NCT01073436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01460498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
ClinicalTrials.gov study NCT06236724. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00003735. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.